The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Hoth Therapeutics HOTH skyrocketed 178.2% on Tuesday after the company announced positive interim safety and efficacy results from a mid-stage study of its lead candidate, HT-001 ...

The scale ensures precise measurement and assessment of skin toxicity improvements. Robb Knie, CEO of Hoth Therapeutics, said, “These results are a significant milestone, underscoring HT-001’s ...

Hoth Therapeutics (NASDAQ:HOTH) shares rose by a staggering 215% today following significant breakthrough in cancer treatment. Their Phase 2a clinical trial of Hoth's topical gel HT-001 has shown ...

(RTTNews) - Hoth Therapeutics (HOTH) has entered into an exclusive patent license agreement with the U.S. Department of Veterans Affairs, providing the company with exclusive rights to a jointly ...

Hoth Therapeutics (HOTH) announced that it has entered into an exclusive patent license agreement with the U.S. Department of Veterans Affairs. This agreement provides Hoth with exclusive rights ...